Isotretinoin, still widely known by the brand name Accutane, has a fearsome reputation. If you are an adult woman weighing it for persistent acne, the internet will hand you a long list of alarming long-term effects, and it is genuinely hard to tell which are real, which are overstated, and which are simply misremembered.
So it is worth separating the one risk that is deadly serious from the ones that turn out to be more reassuring than their reputation. The short version: the pregnancy risk is absolute and permanent, the monitoring during treatment is real, and several of the most-feared long-term harms are not supported by the pooled evidence.
The one risk with no gray area: pregnancy
This is the non-negotiable part. The isotretinoin label carries a boxed warning that it can cause life-threatening birth defects and is contraindicated in pregnancy, and there is an extremely high risk of severe birth defects if pregnancy occurs while taking any amount of it, even briefly. [1] Because of that, it is available only through a restricted safety program called iPLEDGE, which requires monthly pregnancy testing for anyone who can become pregnant. [1] [2]
This matters specifically for women in their 40s. Perimenopause does not switch off fertility, and irregular cycles can make pregnancy easy to miss. If there is any chance of pregnancy, this is the risk that governs everything else about the decision.
The long-term worries that are more reassuring than feared
Two long-term concerns dominate the conversation: mood and bowel disease. The pooled evidence on both is more reassuring than the reputation suggests.
| Concern | What the pooled evidence shows |
|---|---|
| Depression and suicide | A systematic review of 31 studies found the change in depression scores did not differ from other acne treatments, and depression prevalence and scores declined after isotretinoin; it was not associated with increased depression risk [3] |
| Inflammatory bowel disease | A meta-analysis of six studies found no increased risk of inflammatory bowel disease (odds ratio 1.08), and no increased risk of Crohn's disease or ulcerative colitis [4] |
| Lasting acne clearance | In a study of nearly 20,000 patients, about 22.5% relapsed and roughly 8% needed a second course, with higher total dose linked to less relapse [5] |
| Dryness and mucocutaneous effects | Dry skin, lips, and eyes are common during treatment and typically resolve after it ends [2] |
On mood specifically, the researchers concluded that treating acne appears to improve depressive symptoms rather than cause them. [3] That does not mean mood changes never happen to an individual, and any new depression, anxiety, or thoughts of self-harm should be reviewed by a clinician promptly. [2] But the population-level signal does not support the idea that isotretinoin routinely causes depression.
What genuinely needs monitoring
The real, expected medical work of isotretinoin happens during the course, not years later. The label directs fasting lipid tests before treatment and at intervals until the response is known, and liver function tests before and during treatment. [1] Cholesterol and triglycerides can rise, and liver enzymes can shift, which is exactly why these are checked rather than left to chance.
Framed correctly, this is a monitored medication with known, trackable effects, not a mystery. The monitoring is the safety system. For where isotretinoin sits among acne options, see acne treatments ranked by the evidence, and for adult and hormonal acne specifically, see adult acne after menopause treatment.
Where the evidence is limited
It is honest to say the long-term evidence is limited in one specific way: most isotretinoin research is in younger patients. In the large relapse study, the mean age was about 20. [5] Data specifically on adults in their 40s and 50s taking isotretinoin are thinner, so decisions in this age group lean on the general safety picture plus individual factors like other medications, cholesterol, and liver health. That is a reason to individualize the plan with a clinician, not a reason to assume hidden danger.
Red flags: when to seek care during treatment
Most side effects are the manageable, expected kind. A few are warning signs that need prompt attention rather than waiting:
- Any possibility of pregnancy, which is a reason to stop and contact your prescriber immediately.
- New or worsening depression, anxiety, or thoughts of harming yourself, which needs urgent clinical review.
- Severe abdominal pain, persistent diarrhea, or rectal bleeding, which should be evaluated on its own.
- Severe headache with vision changes, nausea, or vomiting, which needs prompt care.
- Sudden decrease in night vision, which should be reported.
Who this fits
Isotretinoin fits adults with severe, scarring, or treatment-resistant acne who can reliably prevent pregnancy and commit to the monitoring, and for whom the psychosocial or physical burden of acne is significant. For that group, it is often the most durably effective option.
It is not a fit for anyone who is or may become pregnant, or who cannot commit to iPLEDGE requirements and blood tests. It is also usually not a first step for mild acne, where topical or other options come first. The decision belongs with a clinician who can weigh your acne severity, your other health factors, and your pregnancy status together.
What to ask your clinician
- Is my acne severe or resistant enough that isotretinoin is the right choice now?
- Given my age and cycle, what pregnancy prevention and testing will iPLEDGE require of me?
- What lipid and liver monitoring will I need, and how often?
- How should I report mood changes, and what would make us pause treatment?
- What total dose are we aiming for, and how does that affect my chance of staying clear?
- What are my alternatives if isotretinoin is not a good fit for me?
Bottom line
Isotretinoin's reputation for long-term harm is mostly heavier than the evidence. The pregnancy risk is absolute and permanent, and it drives the entire iPLEDGE safety system, so preventing pregnancy is the whole ballgame for anyone who could conceive. [1] [2]
Beyond that, the pooled data are reassuring: no increased risk of depression, with mood often improving, and no increased risk of inflammatory bowel disease. [3] [4] The real work is the lipid and liver monitoring during the course, and the payoff is durable clearance for most, with a minority relapsing. [1] [5] Whether it fits you is a monitored, individual decision to make with a clinician.
References
[1] DailyMed. Isotretinoin capsule prescribing information. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31f62a49-4c6d-4ce3-a0ca-d159562370b1
[2] MedlinePlus. Isotretinoin. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a681043.html
[3] Huang YC, Cheng YC. Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis. J Am Acad Dermatol. 2017;76(6):1068-1076.e9. doi:10.1016/j.jaad.2016.12.028 https://pubmed.ncbi.nlm.nih.gov/28291553/
[4] Lee SY, Jamal MM, Nguyen ET, Bechtold ML, Nguyen DL. Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(2):210-6. doi:10.1097/meg.0000000000000496 https://pubmed.ncbi.nlm.nih.gov/26545085/
[5] Lai J, Barbieri JS. Acne Relapse and Isotretinoin Retrial in Patients With Acne. JAMA Dermatol. 2025;161(4):367-374. doi:10.1001/jamadermatol.2024.5416 https://pubmed.ncbi.nlm.nih.gov/39813053/